For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...

The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to get vaccinated ahead of the holidays, when respiratory bugs tend to spread ...

Kids between the ages of 5 and 11 years are “up to date” once they have received the 2024-2025 booster from either Moderna or ...

This action gives people ages 18 years and older the option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed ...

How are the new vaccines different from last fall’s boosters? The updated mRNA vaccines from Moderna and Pfizer-BioNTech target the KP.2 strain, part of the Omicron lineage that began spreading last ...

Moderna, Inc. (NASDAQ:MRNA) is a pharmaceutical and biotechnology ... (rather than government funded), there is increasing ...

while the Covid-19 booster shots will give some recurring revenues, the new RSV vaccine is likely to see increased adoption, amid its advantages over some of the other RSV vaccines. Moderna’s ...

Ward said it would be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking about the population at risk ...

There's one big difference though - Pfizer is seeking a green light for second booster dose of Comirnaty for people aged 60 and over and those in high-risk groups, while Moderna is going for a ...